By Harold P. Adams
Spanning a wide range of issues on the subject of the prognosis and remedy of cerebrovascular affliction, this reference collects the most recent reports and proposals from a crew of seventy five top experts at the subject-including the administration of subarachnoid hemorrhage, the remedy of acute ischemic stroke and aneurysms, and surgical interventions for carotid artery sickness and intracranial vascular illnesses.
Read or Download Handbook of Cerebrovascular Diseases, Second Edition, Revised and Expanded (Neurological Disease and Therapy) PDF
Best neurology books
The invention of microRNAs has published an unforeseen and miraculous extra point of good tuning of the genome and the way genes are used repeatedly in several mixtures to generate the complexity that underlies for example the mind. because the preliminary reports played in C. elegans, we have now long past a much approach to start to know how microRNA pathways could have an influence on healthiness and illness in human.
It is a 3-in-1 reference e-book. It offers an entire clinical dictionary overlaying countless numbers of phrases and expressions in relation to hydrocephalus. It additionally offers wide lists of bibliographic citations. ultimately, it offers details to clients on the way to replace their wisdom utilizing a variety of net assets.
- Progress in Neurology and Psychiatry. An Annual Review
- EEG - fMRI: Physiological Basis, Technique, and Applications
- MOVEMENT DISORDERS 4
- Jefferson Headache Manual
- Apraxia - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
Extra resources for Handbook of Cerebrovascular Diseases, Second Edition, Revised and Expanded (Neurological Disease and Therapy)
Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, Macko RF, Johnson CJ, Earley CJ, Buchholz DW, Hebel JR, Kittner SJ. Antiphospholipid antibodies and stroke in young women. Stroke 2002; 33(10):2396–2401. 72. Ridker PM, Cushman M, Stampfer MJ, et al. Inﬂammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973–979. 73. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inﬂammation in the prediction of cardiovascular events in women.
Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333(24):1581–1587. 95. Cummins RO, et al. Improving survival from sudden cardiac arrest. The ‘‘Chain of Survival’’ concept. Circulation 1991; 83:1832–1847. 96. Rothwell PM. Incidence, risk factors and prognosis of stroke and TIA: the need for high-quality, large-scale epidemiological studies and meta-analyses. Cerebrovasc Dis 2003; 16(suppl 3):2–10. 97. Wattigney WW, Croft JB, Mensah GA, et al. Establishing data elements for the Paul Coverdell National Acute Stroke Registry.
Regular red cell transfusions suﬃcient to reduce the Hb S gene product from over 90% to less than 30% of total hemoglobin was associated with a marked reduction in stroke. The untreated risk of 10% per year was reduced over 90% with treatment. High plasma levels of lipids are an important modiﬁable risk factor for coronary heart disease . Pathophysiological evidence links lipids to major systemic artery disease. However, the role of circulating lipids and lipoproteins in the pathogenesis of ischemic stroke remains uncertain.
Handbook of Cerebrovascular Diseases, Second Edition, Revised and Expanded (Neurological Disease and Therapy) by Harold P. Adams